In summary, to qualify for Ozempic for weight loss, you need to have a BMI of 27 or higher and at least one weight-related health condition
Semaglutide (trade names Rybelsus, Ozempic) is a medication for the treatment of type 2 diabetes
Treatment with OZEMPIC 0.5 mg and 1 mg once weekly for 56 weeks resulted in a statistically significant reduction in HbA1c compared to sitagliptin (see Table 4 and Figure 5)
Oral GLP-1s have low bioavailability, around 0.4 to 1 percent, meaning the tablet needs to remain intact to navigate the stomach efficiently
Our team of experienced physicians at Women's Health Specialists, PLLC is proud to offer a medically supervised weight loss program to our patients, which may include use of GLP-1 medications
Collaborative care between GPs, diabetes specialists, and renal physicians optimises outcomes for patients with complex needs, ensuring that the benefits of Ozempic therapy are realised whilst minimising potential risks to kidney health